Moreover, patients with liver cirrhosis had an increased risk of hypoglycemia, regardless of age, sex, chronic kidney disease, insulin, sulfonylureas, and different types of sulfonylurea, number of oral hypoglycemic agents, β-blocker, and fibrate use. Here, INS is linked to cirrhosis of liver.